Startup

Nagi Bioscience

Description

Nagi Bioscience, a spin-off from EPFL, specializes in pioneering Organism-on-Chip technologies for automated high-content screening of substances, offering a 3R alternative to animal testing. Their cutting-edge laboratory equipment enables end-to-end screenings on micro-organisms, ensuring standardization and reproducibility. By integrating their technology, companies can identify adverse toxicology early in the R&D pipeline, reducing late-stage failures and costs. Nagi's innovative solutions, such as SydLab(tm) ONE, provide powerful methodologies for assessing lifespan and healthspan measures in model systems like C. elegans, offering a more ethical and efficient approach to biological testing.

Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.